Cholesterol esters as growth regulators of lymphocytic leukaemia cells

Cell Proliferation

Volumn 44, Issue 4, 2011, Pages 360-371

  Mulas, M F ^a   Abete, C ^a   Pulisci, D ^a   Pani, A ^a   Massidda, B ^a   Dessi S ^a   Mandas, A ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOSPHOLIPID; PHYTOHEMAGGLUTININ; PROGESTERONE; TRIACYLGLYCEROL;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ISOLATION; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CHOLESTEROL METABOLISM; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GROWTH STIMULATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; LYMPHATIC LEUKEMIA; LYMPHOCYTE COUNT; PHOSPHOLIPID BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AMIDES; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LIPID METABOLISM; LIPIDS; MIDDLE AGED; ORGANOSILICON COMPOUNDS; PHYTOHEMAGGLUTININS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGESTERONE; SIROLIMUS;

EID: 79959718185     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00758.x     Document Type: Article

References (48)

1. Roffo AH (1916) Montevideo: An. Facult. Med.
2. Roffo AH (1933) Heliotropism of cholesterol in relation to skin cancer. Am. J. Cancer. 17, 42-57.
3. Roffo AH, Pilar F (1930) Bol. Inst. Med.Eexp. Estud. y Trat. Cancer 7, 22
4. Yasuda M, Bloor WR (1932) Lipid content of tumors. J. Clin. Invest. 11, 677.
5. Pani A, Dessi S (2003) Cell growth and cholesterol ester. Springer Publication 1-11, 1-150.
6. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387, 569-572.
7. Kurzchalia TV, Parton RG (1999) Membrane microdomains and caveolae. Curr. Opin. Cell Biol. 11, 424-431.
8. Fielding CJ, Fielding PE (2000) Cholesterol and caveolae: structural and functional relationships. Biochim. Biophys. Acta 1529, 210-222.
9. Meinhardt G, Wendtner CM, Hallek M (1999) Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival. J. Mol. Med. 77, 282-293.
10. Stam RW, Schneider P, Hagelstein JA, van der Linden MH, Stumpel DJ, de Menezes RX et al. (2010) Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. Blood 115, 2835-2844.
11. Freeman MR, Solomon KR (2004) Cholesterol and prostate cancer. J. Cell. Biochem. 91, 54-69.
12. Li YC, Park MJ, Ye SK, Kim CW, Kim YN (2006) Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol depleting agents. Am. J. Pathol. 168, 1107-1118.
13. Chan KK, Oza AM, Siu LL (2003) The statins as anticancer agents. Clin. Cancer Res. 9, 10-19.
14. Seeger H, Wallwiener D, Mueck AO (2003) Statins can inhibit proliferation of human breast cancer cells in vitro. Exp. Clin. Endocrinol. Diabetes 111, 47-48.
15. Furuchi T, Anderson RGW (1998) Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J. Biol. Chem. 273, 21099-21104.
16. Chen X, Resh MD (2002) Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J. Biol. Chem. 277, 49631-49637.
17. Westover EJ, Covey DF, Brockman HL, Brown RE, Pike LJ (2003) Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects: studies with cholesterol enantiomers. J. Biol. Chem. 278, 51125-51133.
18. Ness GC, Chambers CM (2000) Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity. Proc. Soc. Exp. Biol. Med. 224, 8-11.
19. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ (1999) c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 274, 8335-8343.
20. Mineo C, Gill GN, Anderson RGW (1999) Regulated migration of epidermal growth factor receptor from caveolae. J. Biol. Chem. 274, 30636-30643.
21. Ringerike T, Glystad FD, Levy FO, Madshus IH, Stang E (2002) Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae. J. Cell Sci. 115, 1331-1340.
22. Warren CM, Landgraf R (2006) Signaling through ERBB receptors: multiple layers of diversity and control. Cell. Signal. 18, 923-933.
23. Grewal T, Enrich C (2009) Annexins - Modulators of EGF receptor signalling and trafficking. Cell. Signal. 21, 847-858.
24. Lambert S, Gniadecki R, Poumay Y (2009) Cholesterol and lipid rafts as regulators of signaling through the EGF receptor in keratinocytes. Open Derm. J. 3, 151-158.
25. Macdonald-Obermann JL, Pike LJ (2009) Palmitoylation of the EGF receptor impairs signal transduction and abolishes high-affinity ligand binding. Biochemistry 48, 2505-2513.
26. Gebhard RL, Clayman RV, Prigge WF, Figenshau R, Staley NA, Reesey C et al. (1987) Abnormal cholesterol metabolism in renal clear cell carcinoma. J. Lipid Res. 28, 1117-1124.
27. Pittman RC, Knecht TP, Resenbaum MS, Taylor CA Jr (1987) A non-endocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. J. Biol. Chem. 262, 2443-2450.
28. Oram JF, Johnson C, Brown TA (1987) Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. J. Biol. Chem. 262, 2405-2410.
29. Dessì S, Batetta B, Pulisci D, Spano O, Cherchi R, Lanfranco G et al. (1992) Altered pattern of lipid metabolism in patients with lung cancer. Oncology 49, 436-441.
30. Umeki S (1993) Decreases in serum cholesterol levels in advanced lung cancer. Respiration 60, 178-181.
31. Siemianowicz K, Gminski J, Stajszczyk M, Wojakowski W, Goss M, Machalski M et al. (2000) Serum HDL cholesterol concentration in patients with squamous cell and small cell lung cancer. Int. J. Mol. Med. 6, 307-311.
32. Dessì S, Batetta B, Pulisci D, Spano O, Anchisi C, Tessitore L et al. (1994) Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 73, 253-258.
33. Dessì S, Batetta B, Spano O, Sanna F, Tonello M, Giacchino M et al. (1995) Clinical remission is associated with restoration of normal high-density lipoprotein cholesterol levels in children with malignancies. Clin. Sci. 89, 505-510.
34. Anchisi C, Batetta B, Sanna F, Fadda AM, Maccioni AM, Dessi S (1995) HDL subfractions as altered in cancer patients. J. Pharm. Biomed. Anal. 13, 65-71.
35. Warnick GR, Benderson J, Albers JJ (1982) Dextran sulfate-Mg21 precipitation procedure for quantification of high-density lipoprotein cholesterol. Clin. Chem. 28, 1379-1388.
36. Pani A, Dessì S, Diaz G, La Colla P, Abete C, Mulas C et al. (2009) Altered cholesterol ester cycle in skin fibroblasts from patients with Alzheimer's disease. J. Alzheimers Dis. 18, 829-841.
37. Musgrove EA, Lee CS, Buckley MF, Sutherland RL (1994) Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA 91, 8022-8026.
38. Engelman JA, Zhang XL, Razani B, Pestell RG, Lisanti MP (1999) p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. J. Biol. Chem. 274, 32333-32341.
39. Uittenbogaard A, Smart E (2000) Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae. J. Biol. Chem. 275, 25595-25599.
40. Majewski M, Korecka M, Kossev P, Li S, Goldman J, Moore J et al. (2000) The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: a potential approach to prevention and treatment of posttransplant lymphoproliferative disorders. Proc. Natl. Acad. Sci. USA 97, 4285-4290.
41. Chen HW, Kandutsch AA, Heininger HJ (1978) The role of cholesterol in malignancy. Prog. Exp. Tumor Res. 22, 275-316.
42. Ho YK, Smith RG, Brown MS, Goldstein JL (1978) Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood 52, 1099-1114.
43. Rudling M, Gafvels M, Parini P, Gahrton G, Angelin B (1998) Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation. Am. J. Pathol. 153, 1923-1935.
44. Harwood HJ, Alvarez IM, Noyes WD, Stacpoole PW (1991) In vivo regulation of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase: increased enzyme protein concentration and catalytic efficiency in human leukemia and lymphoma. J.Lipid Res. 32, 1237-1252.
45. Imbar M, Shinitzky M (1974) Cholesterol as a bioregulator in the development and inhibition of leukemia. Proc. Natl. Acad. Sci. USA 71, 4229-4231.
46. Liscum L, Munn NJ (1999) Intracellular cholesterol transport. Biochim. Biophys. Acta 1438, 19-37.
47. Geyeregger R, Shehata M, Zeyda M, Kiefer FW, Stuhlmeier KM, Porpaczy E et al. (2009) Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes. J. Leukoc. Biol. 86, 1039-1048.
48. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K et al. (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289, 1524-1529.